Medical device maker Boston Scientific Corporation (NYSE: BSX) reported financial results for the first quarter of 2023. The company also provided guidance for the second quarter and fiscal 2023.
- First-quarter net sales increased 12% year-over-year on a reported basis to $3.39 billion
- Net income attributable to stockholders was $300 million or $0.21 per share, compared to $97 million or $0.07 per share last year
- Adjusted earnings, excluding one-off items, increased to $0.47 per share in the three-month period from $0.39 per share in the year-ago quarter
- The management expects net sales to increase between 6.5% and 8.5%, on a reported basis, in the second quarter
- Reported profit is expected to be in the range of $0.23 per share to $0.27 per share in the June quarter
- The guidance for adjusted second-quarter earnings per share is $0.48-$0.50
- In the full fiscal year, net sales are expected to grow in the range of 8.5% to 10.5%
Most Popular
DRI Earnings: Darden Restaurants’ Q2 2026 sales and profit rise YoY
Darden Restaurants, Inc. (NYSE: DRI), a leading fine dining restaurant chain, on Thursday reported an increase in sales and adjusted earnings for the second quarter of fiscal 2026. Total sales
CarMax (KMX) Q3 2026 earnings drop on lower sales; results beat estimates
Used car retailer CarMax, Inc. (NYSE: KMX) on Thursday reported a decline in earnings for the third quarter of fiscal 2026, hurt by lower sales. However, both revenues and earnings
ACN Earnings: Key quarterly highlights from Accenture’s Q1 2026 financial results
Accenture (NYSE: ACN) reported its first quarter 2026 earnings results today. Revenues of $18.7 billion increased 6% in US dollars and 5% in local currency compared to the same period a
